Skip to content

DELFIA Enhancement Solution

by Wallac Oy 3 variants

Ref B118-100

DELFIA Enhancement Solution (B118-100) is an in vitro diagnostic device (EU IVDR Class A; FDA Class I; FDA product code PPM, General Purpose Reagent; EMDN category buffers (unassignable)) made by Wallac Oy, registered in EUDAMED on 30 Jun 2022 (Basic UDI-DI 6438147D_ES6X) and listed in FDA GUDID since 16 Nov 2018 (UDI-DI 06438147009725), active as of 22 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number6438147D_ES6X Basic UDI-DI 06438147009725UDI-DIDate30 Jun 2022RegisteredStatusActive
United StatesGUDID listing GUDID Number06438147009725 UDI-DI Date16 Nov 2018ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
For the quantitative determination of europium (Eu³⁺) and samarium (Sm³⁺) in dissociation-enhanced time-resolved fluoroimmunoassays.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 29 May 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 6438147D_ES6X registered 30 Jun 2022 Active
  • FDA GUDID UDI-DI 06438147009725 listed 16 Nov 2018 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 06438147009725
  2. Registered EUDAMED 6438147D_ES6X

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Generic name
Fluorescent immunoassay dissociation-enhancement reagent IVD
Model / Ref / Catalog
B118-100
Primary DI / UDI-DI
06438147009725
Basic UDI-DI
6438147D_ES6X
FDA product code
PPM
EMDN code
W01029003 Buffers (unassignable), supplem. reagents, etc (ic)
GMDN term
Fluorescent immunoassay dissociation-enhancement reagent IVD
Device class
Class A EUDAMED
Class I GUDID
Regulation number
864.4010
EU registration type
Standard device
EU market of registration
Finland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class A
GUDID
Class I

Device class is stated on each registry's own scale: Class A in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
FI-MF-000022620

Similar devices in this category

Other devices filed under BUFFERS (UNASSIGNABLE), SUPPLEM. REAGENTS, ETC (IC).

Other devices from Wallac Oy

See all devices from Wallac Oy →

Properties

  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (19, all answered No)